Exploring the mechanism of F282L mutation-caused constitutive activity of GPCR by a computational study

Nan Gao1, Tao Liang1, Yuan Yuan2

  • 1Faculty of Chemistry, Sichuan University, Chengdu, Sichuan 610064, People's Republic of China. xmpuscu@scu.edu.cn.

Insights

Constitutive active mutations (CAMs) in G-protein-coupled receptors (GPCRs) can cause disease. Molecular dynamics simulations reveal the F282L mutation in β2AR increases structural instability, promoting constitutive activity and influencing drug interactions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • G-protein-coupled receptors (GPCRs) are crucial drug targets, typically activated by ligands.
  • Certain mutations lead to constitutive receptor activity (CAMs), often linked to diseases.
  • The precise mechanisms of CAMs and their impact on drug binding remain incompletely understood.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the F282L mutation's effect on β2AR.
  • To elucidate how this mutation contributes to constitutive activity and influences drug-ligand interactions.

Main Methods:

  • Microsecond molecular dynamics simulations.
  • Principle component and correlation analysis.
  • Protein structure network (PSN) analysis.
  • Virtual screening.

Main Results:

  • The F282L mutation increases β2AR structural instability and fluctuations in key regions (NPxxY motif, extracellular loops).
  • It weakens interhelical H-bonding and residue correlations, reducing helical restraint.
  • The mutation alters signal transmission pathways, enhancing TM3's role in the orthosteric site and TM4's in the allosteric site.
  • Virtual screening indicates the mutant preferentially binds agonists, mimicking an active receptor state.

Conclusions:

  • The F282L mutation promotes β2AR activation, contributing to its constitutive activity.
  • This mutation impacts GPCR structural dynamics and signal transduction pathways.
  • Findings offer insights into mutation-driven GPCR activity and inform rational drug design for GPCR-related diseases.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.3K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.5K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K